PK PHARMA CONSULT
Enterprise number 0750549277 · Insolvent (050 Opening faillissement)
PK PHARMA CONSULT is a besloten vennootschap registered in Villers-le-Bouillet, Belgium, incorporated on 10 Jul 2020. Its registered activity is overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering. The company entered insolvency.
Company details
- Enterprise number
- 0750549277 · official register
- Status
- 050 Opening faillissement
- Legal form
- Besloten Vennootschap
- Incorporated
- 10 Jul 2020
- Registered address
- 4530 Villers-le-Bouillet
- Province
- Liège
- Activity
- 70220 Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
- Industry
- Head offices; management consultancy
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Liège
- "Devel'up" Faimes
- "VM MANAGEMENT" Dalhem
- 14 MANAGEMENT Grâce-Hollogne
- 2 the point services Herve
- 2-FLOW Liège
- 21 Liège
- 2ABC Flémalle
- 2D CONSEIL Sprimont
- 2H Invest Liège
- 2N CONSULT Welkenraedt
- 2P MANAGEMENT & CONSTRUCTION Soumagne
- 3 L Consulting Liège
Questions about PK PHARMA CONSULT
What is the enterprise number of PK PHARMA CONSULT?
PK PHARMA CONSULT is registered under enterprise number 0750549277 in the official register of Belgium. View it at the official register.
Is PK PHARMA CONSULT still active?
No. PK PHARMA CONSULT is insolvent.
Has PK PHARMA CONSULT gone bankrupt or into insolvency?
Yes. PK PHARMA CONSULT entered insolvency.
When was PK PHARMA CONSULT founded?
PK PHARMA CONSULT was incorporated on 10 Jul 2020.
Where is PK PHARMA CONSULT registered?
PK PHARMA CONSULT's registered address is in 4530 Villers-le-Bouillet (Liège), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.